Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
262 participants
OBSERVATIONAL
2024-01-31
2033-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
NCT02729402
Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus
NCT06940726
Aging, Cognition, and Hearing Evaluation in Elders Study
NCT02412254
Evaluation of Hearing Aids Rehabilitation Within Age-related Hearing Loss Population.
NCT05331404
Correlation Between Prognosis of Mild Cognitive Impairment and Hearing Function in Community Elderly
NCT05336942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hearing subject
Adult normal hearing subjects, evaluated annually for 5 years,
auditory level
* Evaluation of auditory thresholds through audiometric tests.
* Evaluation of speech comprehension in noise through a vocal audiometry test in noise (FraMatrix).
* Evaluation of spatial auditory behavior and spatial precision using a spatial discrimination test (Minimum Audible Angle) and a static sound localization test in virtual reality.
cognitive level
* Evaluation of attention and short-term memory functions with verbal and non-verbal tasks: Digit Span Test and Reading Span Test.
* Evaluation of inhibition capacities using the Stroop Test.
* Evaluation of executive functions, visual attention, reasoning, and mental arithmetic using the Raven's Matrix test.
quality of life level
\- Evaluation of quality of live level via Speech, Spatial and Qualities of Hearing Scale (SSQ-12) and EuroQol-5D questionnaires.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
auditory level
* Evaluation of auditory thresholds through audiometric tests.
* Evaluation of speech comprehension in noise through a vocal audiometry test in noise (FraMatrix).
* Evaluation of spatial auditory behavior and spatial precision using a spatial discrimination test (Minimum Audible Angle) and a static sound localization test in virtual reality.
cognitive level
* Evaluation of attention and short-term memory functions with verbal and non-verbal tasks: Digit Span Test and Reading Span Test.
* Evaluation of inhibition capacities using the Stroop Test.
* Evaluation of executive functions, visual attention, reasoning, and mental arithmetic using the Raven's Matrix test.
quality of life level
\- Evaluation of quality of live level via Speech, Spatial and Qualities of Hearing Scale (SSQ-12) and EuroQol-5D questionnaires.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residency in one of the three neighborhoods :
* Affiliation with a social security system
Exclusion Criteria
* History of neurological pathologies
* Taking of psychotropic medication.
45 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mathieu Marx, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ecole d'audioprothèse
Cahors, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mariam ALZAHER, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01415-40
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/22/0252
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.